Loading data for DRIO — first visit, this takes a few seconds.
DarioHealth Corp. (DRIO)
NasdaqCM: DRIO
· Real-Time Price · USD
7.02
-0.35 (-4.75%)
At close: Sep 02, 2026, 8:00 PM
The price, the headline numbers and the latest news, in one place.
DarioHealth Corp. (DRIO) Stock Price, Analysis & Data
No data available
| Bid | 5.17 |
| Market Cap | 71.5M |
| Revenue (ttm) | 21M |
| Net Income (ttm) | -7M |
| 1.12 | |
| -14.87 | |
| n/a | |
| -6.52 | |
| P/B (ttm) | 0.97 |
| P/S (ttm) | 3.41 |
| Earnings Date | Nov 12, 2026 |
| Ask | 8.96 |
| Volume | 40,022 |
| Avg. Volume (20D) | 20,579 |
| Open | 7.43 |
| Previous Close | 7.37 |
| Day's Range | 6.79 - 7.57 |
| 52-Week Range | 5.84 - 17.74 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | n/a |
| Ex-Dividend Date | n/a |
About DRIO
DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to...
Industry Health Information Services
Sector Healthcare
IPO Date Mar 14, 2016
Employees 160
Stock Exchange NasdaqCM
Ticker Symbol DRIO
Website https://www.dariohealth.com
Financial Performance
In 2025, DarioHealth's revenue was 22.36M, a decrease of -17.31% compared to the previous year's 27.04M. Earnings were -41.71M, a decrease of -2.42%.
Financial StatementsEarnings Surprise
DarioHealth has released their quarterly earnings on Aug 11, 2026:
- Revenue of $5.58M misses estimates by $0, with -17.30% YoY decline.
- EPS of -0.73 exceeds estimates by 0.02, with 82.15% YoY growth.
DarioHealth Corp. is scheduled to release its earnings on Nov 12, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2


